World Health Organisation. WHO coronavirus (COVID-19) dashboard Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

Ghebreyesus TA. WHO director-General's opening remarks at the media briefing on COVID-19. 2020. Geneva: World Health Organization; 2020.

Google Scholar 

Olum R, Bongomin F. Uganda’s first 100 COVID-19 cases: trends and lessons. Int J Infect Dis. 2020;96:517–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Worldometer. COVID-19 Coronavirus Pandemic 2021 Available from: https://www.worldometers.info/coronavirus/country/uganda/.

Google Scholar 

Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 2021;97(1147):312–20.

Article  PubMed  Google Scholar 

Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: an overview. J Chin Med Assoc. 2020;83(3):217–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parekh R, Zhang X, Ungaro RC, Brenner EJ, Agrawal M, Colombel J-F, et al. Presence of comorbidities associated with severe coronavirus infection in patients with inflammatory bowel disease. Dig Dis Sci. 2022;67(4):1271–7.

Article  CAS  PubMed  Google Scholar 

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020;395(10229):1054–62.

Article  CAS  Google Scholar 

Boari GEM, Chiarini G, Bonetti S, Malerba P, Bianco G, Faustini C, et al. Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Biosci Rep. 2020;40(12).

Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a Nationwide analysis in China. Chest. 2020;158(1):97–105.

Article  CAS  PubMed  Google Scholar 

Salinas-Escudero G, Carrillo-Vega MF, Granados-García V, Martínez-Valverde S, Toledano-Toledano F, Garduño-Espinosa J. A survival analysis of COVID-19 in the Mexican population. BMC Public Health. 2020;20(1):1–8.

Google Scholar 

Kundu S, Chauhan K, Mandal D. Survival analysis of patients with COVID-19 in India by demographic factors: quantitative study. JMIR Format Res. 2021;5(5):e23251.

Article  Google Scholar 

Altonen BL, Arreglado TM, Leroux O, Murray-Ramcharan M, Engdahl R. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City. PLoS One. 2020;15(12):e0243343.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bongomin F, Fleischer B, Olum R, Natukunda B, Kiguli S, Byakika-Kibwika P, et al. High mortality during the second wave of the coronavirus disease 2019 (COVID-19) pandemic in Uganda: experience from a National Referral COVID-19 treatment unit. Open Forum Infect Dis. 2021;8(11).

Abate SM, Checkol YA, Mantedafro B, Basu B, Ethiopia D. Prevalence and risk factors of mortality among hospitalized patients with COVID-19: a systematic review and Meta-analysis. Bull World Health Organ. 2020;10(45):6.

Google Scholar 

Sousa GJB, Garces TS, Cestari VRF, Florêncio RS, Moreira TMM, Pereira MLD. Mortality and survival of COVID-19. Epidemiol Infect. 2020;148:e123.

Article  CAS  PubMed  Google Scholar 

Eyu P, Elyanu P, Ario AR, Ntono V, Birungi D, Rukundo G, et al. Investigation of possible preventable causes of COVID-19 deaths in the Kampala metropolitan area, Uganda, 2020–2021. Int J Infect Dis. 2022;122:10–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jassat W, Mudara C, Ozougwu L, Tempia S, Blumberg L, Davies M-A, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021;9(9):e1216–25.

Article  PubMed  PubMed Central  Google Scholar 

Hatamabadi H, Sabaghian T, Sadeghi A, Heidari K, Safavi-Naini SAA, Looha MA, et al. Epidemiology of COVID-19 in Tehran, Iran: a cohort study of clinical profile, risk factors, and outcomes. Biomed Res Int. 2022;2022:2350063.

Article  PubMed  PubMed Central  Google Scholar 

Nlandu Y, Mafuta D, Sakaji J, Brecknell M, Engole Y, Abatha J, et al. Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study. BMC Infect Dis. 2021;21(1):1272.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(5):e0250602.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bong CL, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 pandemic: effects on low- and middle-income countries. Anesth Analg. 2020;131(1):86–92.

Article  CAS  PubMed  Google Scholar 

Miller IF, Becker AD, Grenfell BT, Metcalf CJE. Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020;26(8):1212–7.

Article  CAS  PubMed  Google Scholar 

Hamid H, Abid Z, Amir A, Rehman TU, Akram W, Mehboob T. Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19. Drugs Ther Perspect. 2020:1–3.

Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg (London, England). 2020;78:185–93.

Article  Google Scholar 

Khalid F, Abbasi AN. Challenges faced by Pakistani healthcare system: Clinician's perspective. J Coll Phys Surg-Pakistan. 2018;28(12):899–901.

Google Scholar 

Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021;596(7871):276–80.

Article  CAS  PubMed  Google Scholar 

Biswas B, Chattopadhyay S, Hazra S, Hansda AK, Goswami R. COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines. Inflamm Res. 2022;71(4):377–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaso AW, Agero G, Hurissa Z, Kaso T, Ewune HA, Hareru HE, et al. Survival analysis of COVID-19 patients in Ethiopia: a hospital-based study. PLoS One. 2022;17(5):e0268280.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhandari S, Tak A, Singhal S, Shukla J, Shaktawat AS, Gupta J, et al. Patient flow dynamics in hospital systems during times of COVID-19: cox proportional Hazard regression analysis. Front Public Health. 2020;8:585850.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a Regionwide registry study. J Am Soc Nephrol. 2021;32(2):385–96.

Article  PubMed  Google Scholar 

Munster VJ, Flagg M, Singh M, Williamson BN, Feldmann F, Pérez-Pérez L, et al. Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques. bioRxiv. 2021.

Tessema GA, Kinfu Y, Dachew BA, Tesema AG, Assefa Y, Alene KA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Glob Health. 2021;6(12):e007179.

Article  PubMed  Google Scholar 

Ali MM, Malik MR, Ahmed AY, Bashir AM, Mohamed A, Abdi A, et al. Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 march–12 June 2020: which interventions are proving effective in fragile states? Int J Infect Dis. 2022;114:202–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gardner ID. The effect of aging on susceptibility to infection. Rev Infect Dis. 1980;2(5):801–10.

Article  CAS  PubMed  Google Scholar 

Lu ZH, Yu WL, Sun Y. Multiple immune function impairments in diabetic patients and their effects on COVID-19. World J Clin Cases. 2021;9(24):6969–78.

Article  PubMed  PubMed Central  Google Scholar 

Zhong B, Wang Y, Zhang G. History of diabetes mellitus is associated with elevated cardiac troponin I levels in patients with chest pain but no coronary heart disease. Cardiol J. 2016;23(2):149–54.

Article  PubMed  Google Scholar 

Wega AB, Wabalo EK, Edae CK, Awgichew GB. Cardiac troponin-I status of Type-2 diabetic patients on anti-diabetic drugs treatment at Jimma medical center, Jimma, Southwest Ethiopia. Res Rep Clin Cardiol. 2021;12:1.

Google Scholar 

De Marzo V, Di Biagio A, Della Bona R, Vena A, Arboscello E, Emirjona H, et al. Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19. J Geriatr Cardiol. 2021;18(5):338–45.

PubMed  PubMed Central  Google Scholar 

Fan G, Tu C, Zhou F, Liu Z, Wang Y, Song B, et al. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020;56(3):2002113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arias Ramos D, Restrepo Rueda DL, Rios Quintero EV, Olaya Gómez JC, Cortés Bonilla I. Severe and critical COVID-19 in a tertiary center in Colombia, a retrospective cross-sectional study. BMC Infect Dis. 2022;22(1):247.